Cramer’s lightning round includes a fintech ‘on the road to redemption’

Cramer’s lightning round includes a fintech ‘on the road to redemption’


PayPal (PYPL): “PayPal did very well today. They are already on the road to redemption.”

MicroVision (MVIS): “It’s a $3 stock. It’s a dice roll. It could go down $3. Stocks stop at zero. It is losing a lot of money. So therefore, it’s not my cup of tea.”

Verizon (VZ): “Verizon’s got that big [annual dividend] yield. But it looks like AT&T has finally passed them. And I am concerned they [Verizon] are going to have to spend a lot more to get back in competition with AT&T. So right now, I cannot recommend the stock of Verizon.”

Signature Bank (SBNY): “I think the stock is probably incorrectly valued. But it does not have a big [annual dividend] yield. Most of the bank stocks have a good yield and are levered to the yield curve [in the bond market], so to speak. … It’s not going to react as well as some of the traditional banks.”

Cummins (CMI): “I think Cummins is a great company. This is the kind of stock that is working right now in this environment. It doesn’t really get hurt much by rates. … It’s got superior products [that] it’s selling all over the world. I like Cummins.”

Sign up now for the CNBC Investing Club to follow Jim Cramer’s every move in the market.

Disclaimer

Questions for Cramer?
Call Cramer: 1-800-743-CNBC

Want to take a deep dive into Cramer’s world? Hit him up!
Mad Money TwitterJim Cramer Twitter – Facebook – Instagram

Questions, comments, suggestions for the “Mad Money” website? [email protected]





Source

Nike cuts 1,400 roles in second round of layoffs this year
Business

Nike cuts 1,400 roles in second round of layoffs this year

People walk past a Nike store in New York City, on April 2, 2025. Kylie Cooper | Reuters Nike announced a new round of layoffs on Thursday impacting approximately 1,400 roles across the organization, mostly concentrated in its technology department. In a note from COO Venkatesh Alagirisamy, the company said the layoffs were part of […]

Read More
Trump administration moves to reclassify cannabis in major shift that could expand research
Business

Trump administration moves to reclassify cannabis in major shift that could expand research

The Trump administration moved Thursday to reclassify cannabis under federal law, which could significantly expand scientific research into the drug’s medical uses. The change would not legalize the drug at the federal level, but shift cannabis from its current status as a Schedule I substance to Schedule III under the U.S. Drug Enforcement Administration’s controlled […]

Read More
Regeneron inks drug pricing deal with Trump, will offer new hearing-loss therapy for free
Business

Regeneron inks drug pricing deal with Trump, will offer new hearing-loss therapy for free

U.S. President Donald Trump (C) speaks during an event on advancing health care affordability in the Oval Office of the White House on April 23, 2026 in Washington, DC. Alex Wong | Getty Images Regeneron agreed to lower U.S. drug prices for some Americans as part of a deal with President Donald Trump, the White […]

Read More